✦ LIBER ✦

Therapeutic use of recombinant methionyl human leptin

✍ Scribed by Vatier, Camille; Gautier, Jean-François; Vigouroux, Corinne

Book ID: 119195798
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 213 KB
Volume: 94
Category: Article
ISSN: 0300-9084
DOI: 10.1016/j.biochi.2012.03.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differentiation and quantification of en

Differentiation and quantification of endogenous and recombinant-methionyl human leptin in clinical plasma samples by immunocapture/mass spectrometry

✍ Yan Wang; Joseph S. Heilig 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Recombinant human alpha-1 proteinase inh

Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use

✍ E. Karnaukhova; Y. Ophir; B. Golding 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 172 KB

In Vitro Methionine Oxidation of Recombi

In Vitro Methionine Oxidation of Recombinant Human Leptin

✍ Jennifer L. Liu; Kan V. Lu; Tamer Eris; Viswanatham Katta; Keith R. Westcott; Li 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 802 KB

Effect of three treatment schedules of r

Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial

✍ P. M. J. Zelissen; K. Stenlof; M. E. J. Lean; J. Fogteloo; E. T. P. Keulen; J. W 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Diagnostic and therapeutic use of recomb

Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer

✍ Furio Pacini; Maria Grazia Castagna 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Tolerability of recombinant-methionyl hu

Tolerability of recombinant-methionyl human neurotrophin-3 (r-metHuNT3) in healthy subjects

✍ V. Chaudhry; M. Giuliani; B.G. Petty; D. Lee; M. Seyedsadr; D. Hilt; D.R. Cornbl 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

This phase I, double-blind, randomized, placebo-controlled study evaluated the safety of single and multiple (daily for 7 days) subcutaneous administrations of recombinant-methionyl human neurotrophin-3 (r-metHuNT3) in healthy human volunteers at seven doses, ranging from 3 to 500 µg/kg/day. No seri